BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9775281)

  • 21. Evidence-based orthopaedics: a primer.
    Schünemann HJ; Bone L
    Clin Orthop Relat Res; 2003 Aug; (413):117-32. PubMed ID: 12897602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stroke--possibilities for prevention].
    Kolominsky-Rabas P
    Biomed Tech (Berl); 2005; 50(7-8):233-7. PubMed ID: 16117437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions.
    Mayne TJ; Whalen E; Vu A
    J Clin Epidemiol; 2006 Mar; 59(3):217-23. PubMed ID: 16488351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating adjusted NNT measures in logistic regression analysis.
    Bender R; Kuss O; Hildebrandt M; Gehrmann U
    Stat Med; 2007 Dec; 26(30):5586-95. PubMed ID: 17879268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Number needed to treat: a useful tool for estimating the effectiveness of a treatment].
    van Harten PN
    Tijdschr Psychiatr; 2008; 50(6):337-43. PubMed ID: 18548411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primer: Demystifying risk--understanding and communicating medical risks.
    Crowson CS; Therneau TM; Matteson EL; Gabriel SE
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):181-7; quiz 1 p following 187. PubMed ID: 17334341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk and odds--how to calculate with events].
    Malmquist J
    Lakartidningen; 2002 Feb; 99(8):751-3, 756. PubMed ID: 11894612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based medicine, part 2. An introduction to critical appraisal of articles on therapy.
    Cardarelli R; Virgilio RF; Taylor L
    J Am Osteopath Assoc; 2007 Aug; 107(8):299-303. PubMed ID: 17785686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deriving treatment recommendations from evidence within randomized trials. The role and limitation of meta-analysis.
    Freemantle N; Mason J; Eccles M
    Int J Technol Assess Health Care; 1999; 15(2):304-15. PubMed ID: 10507190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Search and appraisal of literatures and methods to use Internets in evidence based neurology].
    Uchiyama S
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1182-5. PubMed ID: 12784700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat.
    Gensini GF; Conti AA
    Ital Heart J; 2003 Feb; 4(2):80-3. PubMed ID: 12762269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing pressure ulcer incidence through Braden Scale risk assessment and support surface use.
    Comfort EH
    Adv Skin Wound Care; 2008 Jul; 21(7):330-4. PubMed ID: 18600075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of the 'reverse Cornfield inequality' to assess the sensitivity of a non-significant association to an omitted variable.
    Yu B; Gastwirth JL
    Stat Med; 2003 Nov; 22(21):3383-401. PubMed ID: 14566922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressing medicine side effects: assessing the effectiveness of absolute risk, relative risk, and number needed to harm, and the provision of baseline risk information.
    Berry DC; Knapp P; Raynor T
    Patient Educ Couns; 2006 Oct; 63(1-2):89-96. PubMed ID: 16242904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative risks and odds ratios: what's the difference?
    Last A; Wilson S
    J Fam Pract; 2004 Feb; 53(2):108. PubMed ID: 14764292
    [No Abstract]   [Full Text] [Related]  

  • 37. [Assessment of therapeutic efficacy, an essential step in evidence-based medicine].
    Scheen AJ
    Rev Med Liege; 2000 Apr; 55(4):206-10. PubMed ID: 10909301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measures of effect in epidemiological research.
    Tripepi G; Jager KJ; Dekker FW; Zoccali C
    Nephron Clin Pract; 2010; 115(2):c91-3. PubMed ID: 20407271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating a treatment effect: Choosing between relative and absolute measures.
    Sormani MP; Bruzzi P
    Mult Scler; 2017 Feb; 23(2):197-200. PubMed ID: 27207463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Odds ratio, relative risk, absolute risk reduction, and the number needed to treat--which of these should we use?
    Schechtman E
    Value Health; 2002; 5(5):431-6. PubMed ID: 12201860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.